IVF
INVO Fertility, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$0.60
+7.78%Year over year
Reported trailing growth
- Revenue
- +13.8%
- EBITDA
- +74.6%
- EBIT
- +36.5%
- EPS
- +92.4%
- Free cash flow
- +27.4%
- Operating cash flow
- +26.9%
Forward estimates
Based on analyst estimates
- Revenue
- +26.1%
- EBITDA
- +84.5%
- EPS
- +98.2%
Three-year CAGR
- Revenue
- +102.6%
- EBITDA
- +50.9%
- EBIT
- +28.1%
- Net income
- —
- EPS
- +97.9%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026